303 related articles for article (PubMed ID: 24052421)
1. SUMO: a (oxidative) stressed protein.
Feligioni M; Nisticò R
Neuromolecular Med; 2013 Dec; 15(4):707-19. PubMed ID: 24052421
[TBL] [Abstract][Full Text] [Related]
2. SUMO and Parkinson's disease.
Eckermann K
Neuromolecular Med; 2013 Dec; 15(4):737-59. PubMed ID: 23979994
[TBL] [Abstract][Full Text] [Related]
3. SUMO and Alzheimer's disease.
Lee L; Sakurai M; Matsuzaki S; Arancio O; Fraser P
Neuromolecular Med; 2013 Dec; 15(4):720-36. PubMed ID: 23979993
[TBL] [Abstract][Full Text] [Related]
4. Control of SUMO and Ubiquitin by ROS: Signaling and disease implications.
Stankovic-Valentin N; Melchior F
Mol Aspects Med; 2018 Oct; 63():3-17. PubMed ID: 30059710
[TBL] [Abstract][Full Text] [Related]
5. Protein sumoylation in brain development, neuronal morphology and spinogenesis.
Gwizdek C; Cassé F; Martin S
Neuromolecular Med; 2013 Dec; 15(4):677-91. PubMed ID: 23907729
[TBL] [Abstract][Full Text] [Related]
6. SUMO rules: regulatory concepts and their implication in neurologic functions.
Droescher M; Chaugule VK; Pichler A
Neuromolecular Med; 2013 Dec; 15(4):639-60. PubMed ID: 23990202
[TBL] [Abstract][Full Text] [Related]
7. Receptor trafficking and the regulation of synaptic plasticity by SUMO.
Luo J; Ashikaga E; Rubin PP; Heimann MJ; Hildick KL; Bishop P; Girach F; Josa-Prado F; Tang LT; Carmichael RE; Henley JM; Wilkinson KA
Neuromolecular Med; 2013 Dec; 15(4):692-706. PubMed ID: 23934328
[TBL] [Abstract][Full Text] [Related]
8. Sumoylation in neurodegenerative diseases.
Krumova P; Weishaupt JH
Cell Mol Life Sci; 2013 Jun; 70(12):2123-38. PubMed ID: 23007842
[TBL] [Abstract][Full Text] [Related]
9. Proteomics strategies to identify SUMO targets and acceptor sites: a survey of RNA-binding proteins SUMOylation.
Filosa G; Barabino SM; Bachi A
Neuromolecular Med; 2013 Dec; 15(4):661-76. PubMed ID: 23979992
[TBL] [Abstract][Full Text] [Related]
10. The SUMO E3-ligase PIAS1 couples reactive oxygen species-dependent JNK activation to oxidative cell death.
Leitao BB; Jones MC; Brosens JJ
FASEB J; 2011 Oct; 25(10):3416-25. PubMed ID: 21676946
[TBL] [Abstract][Full Text] [Related]
11. SUMOylation in Neurodegenerative Diseases.
Princz A; Tavernarakis N
Gerontology; 2020; 66(2):122-130. PubMed ID: 31505513
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress-enhanced SUMOylation and aggregation of ataxin-1: Implication of JNK pathway.
Ryu J; Cho S; Park BC; Lee DH
Biochem Biophys Res Commun; 2010 Mar; 393(2):280-5. PubMed ID: 20132795
[TBL] [Abstract][Full Text] [Related]
13. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
[TBL] [Abstract][Full Text] [Related]
14. [Reactive Oxygen Species (ROS) Signaling: Regulatory Mechanisms and Pathophysiological Roles].
Hirata Y
Yakugaku Zasshi; 2019; 139(10):1235-1241. PubMed ID: 31582606
[TBL] [Abstract][Full Text] [Related]
15. The pivotal role of SUMO-1-JNK-Tau axis in an in vitro model of oxidative stress counteracted by the protective effect of curcumin.
Buccarello L; Dragotto J; Iorio F; Hassanzadeh K; Corbo M; Feligioni M
Biochem Pharmacol; 2020 Aug; 178():114066. PubMed ID: 32502496
[TBL] [Abstract][Full Text] [Related]
16. SUMO on the road to neurodegeneration.
Dorval V; Fraser PE
Biochim Biophys Acta; 2007 Jun; 1773(6):694-706. PubMed ID: 17475350
[TBL] [Abstract][Full Text] [Related]
17. Sumoylation of p35 modulates p35/cyclin-dependent kinase (Cdk) 5 complex activity.
Büchner A; Krumova P; Ganesan S; Bähr M; Eckermann K; Weishaupt JH
Neuromolecular Med; 2015 Mar; 17(1):12-23. PubMed ID: 25391294
[TBL] [Abstract][Full Text] [Related]
18. Cross talk of signaling pathways in the regulation of the glucocorticoid receptor function.
Davies L; Karthikeyan N; Lynch JT; Sial EA; Gkourtsa A; Demonacos C; Krstic-Demonacos M
Mol Endocrinol; 2008 Jun; 22(6):1331-44. PubMed ID: 18337589
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between JNK and SUMO signaling pathways: deSUMOylation is protective against H2O2-induced cell injury.
Feligioni M; Brambilla E; Camassa A; Sclip A; Arnaboldi A; Morelli F; Antoniou X; Borsello T
PLoS One; 2011; 6(12):e28185. PubMed ID: 22164242
[TBL] [Abstract][Full Text] [Related]
20. SUMO and ischemic tolerance.
Lee YJ; Hallenbeck JM
Neuromolecular Med; 2013 Dec; 15(4):771-81. PubMed ID: 23775726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
